In this study, we investigated the protein levels of SIRT4 in BLCA by immunohistochemical techniques on high-throughput tissue microarrays, analyzed the relationship between SIRT4 levels and clinicopathological parameters in BLCA patients and assessed the prognostic value. The gene discussed is SIRT4; the disease is bladder transitional cell carcinoma.